All In MedTech

Device Trial Radar · NCT03209609

VEST Venous Graft External Support Pivotal Study

A Multi-center, Randomized, Within-subject-controlled, Open Label Study of the Safety and Effectiveness of VEST, Venous External Support

Last checked: Nov 20, 2026Latest source record: Feb 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingTitle says "pivotal". Randomized with 224 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

224

Actual

Start

Jan 9, 2018

Primary completion

Sep 29, 2020

Study completion Sep 25, 2024

Sponsor

Lead sponsor
Vascular Graft Solutions Ltd.Not on our public-company list
Sponsor type
Industry
Collaborators
International Center for Health Outcomes and Innovation Research
First posted
Jul 6, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective, multi-center, randomized, within-subject-controlled , trial, enrolling patients with multi vessel atherosclerotic coronary artery disease, scheduled to undergo SVG CABG with arterial grafting of IMA to LAD and two or more saphenous vein grafts. In each patient, one SVG bypass will be randomized to be supported by the VEST, while another will not be supported and serve as control. Thus, the full cohort will provide a basis for comparison between two sets of SVGs: A VEST supported set; and an unsupported set.

Conditions

  • Coronary Artery Disease

Interventions

  • VESTDevice

    External support for vein grafts, cobalt chrome braid

  • Coronary artery bypass vein graftsProcedure

    Bypass coronary arteries with autologous saphenous vein grafts

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Intimal hyperplasia area/graft occlusionTime frame: 1 year

Locations

17 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Southern California

    Los Angeles, California

16 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.